Related content

Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN)

By Schiel R.   Franke S.   Appel T.   Voigt U.   Ross I.S.   Kientsch-Engel R.   Stein G.   Muller U.A.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 2, 2003-03 ,pp. : 90-97

Elsevier

Access to resources Recommend Favorite

Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland

By Pechère Antoinette   Greminger Peter   Hess Lorenzo   Philippe Jacques   Ferrari Paolo  

Blood Pressure, Vol. 14, Iss. 6, 2005-12 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Insulin resistance is a risk factor for progression to Type 1 diabetes

By Fourlanos S.   Narendran P.   Byrnes G.   Colman P.   Harrison L.  

Diabetologia, Vol. 47, Iss. 10, 2004-10 ,pp. : 1661-1667

Springer Publishing Company

Access to resources Recommend Favorite

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

By Bellia Alfonso   Babini Anna   Marchetto Paolo   Arsenio Leone   Lauro Davide   Lauro Renato  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

By Clarke P.   Gray A.   Briggs A.   Farmer A.   Fenn P.   Stevens R.   Matthews D.   Stratton I.   Holman R.  

Diabetologia, Vol. 47, Iss. 10, 2004-10 ,pp. : 1747-1759

Springer Publishing Company

Access to resources Recommend Favorite